fashion -WSS

fashion

author：Wikipedia 2025-09-02 17:34:32 - browse：82

Mel Evans/AP

Merck announced Monday it will acquire Harpoon Therapeutics and its pipeline of immune-based cancer drugs for $680 million. Merck will pay $23 per share, just over twice Harpoon’s market price entering the week.

The bolt-on deal comes as Merck’s top brass searches for ways to bolster the company’s revenue after it loses exclusivity on Keytruda, long the world’s most lucrative cancer drug. That could come as soon as 2028.

Keytruda, a PD-(L)1 inhibitor, works by turning off a “brake” on T cells, allowing roving immune cells to attack tumors. Harpoon’s pipeline belongs to a new class of cancer drugs designed to grab onto the T cells and tumor cells and bring them together.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Leading voice in opioid treatment defends methadone clinic system

hotspot

WSS

Readout Newsletter: Bluebird, CVS, Contineum

Future doctors should be trained to promote social change

Leading voice in opioid treatment defends methadone clinic system

CommonSpirit Health keeps growing, even as it loses money

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Virtual Event: March of the Biosimilars

entertainment

fashion

leisure time

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Health AI adoption puts security, privacy startups on investors' radar

Jerome Adams on the need for new antivirals for Covid

Experts study whether long Covid risk adds up with each reinfection

Moonlake's readout produced a cash windfall. Risks remain

Senators: Long

FDA approval of Sarepta Duchenne genetic therapy gives me hope

How Vertex's cystic fibrosis drug is changing patients' lives

23andMe had bad news about my health. I wish a person had delivered it

CommonSpirit Health keeps growing, even as it loses money

Wikipedia

Why are Kaiser Permanente staff considering a strike?

CommonSpirit Health keeps growing, even as it loses money

Second xenotransplant done with gene

UnitedHealth increases loan offers after Change Healthcare outage

Ukraine and a new approach to mental health in war

Emergency workers more likely to restrain Black patients: study

leisure time

hotspot

explore

Wikipedia